Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
- 2011 -
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
January 2011 - 47 products
L
IP
CI
Dexeryl
50 g
2.49
4.60
10 %
Cream: 3 Active Agents
Pierre Fabre Pharma SA
D / SL / SO
FB
G
L
IP
CI
Dexeryl
250 g
8.15
11.15
10 %
Cream: 3 Active Agents
Pierre Fabre Pharma SA
D / SL / SO
FB
G
L
IP
CI
Gilenya 0.5 mg
28 Tablet(s)
879.66
942.35
20 %
Capsules: Fingolimodum
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Gilenya 0.5 mg
98 Tablet(s)
3078.80
3257.25
20 %
Capsules: Fingolimodum
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Cansartan-Mepha plus
8/12.5
28 Tablet(s)
7.27
17.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
8/12.5
98 Tablet(s)
23.77
42.35
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
16/12.5
28 Tablet(s)
9.01
26.25
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
16/12.5
98 Tablet(s)
31.45
50.70
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
32/12.5
28 Tablet(s)
9.84
27.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
32/12.5
98 Tablet(s)
32.37
51.75
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
32/25
28 Tablet(s)
9.84
27.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Cansartan-Mepha plus
32/25
98 Tablet(s)
32.37
51.75
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Docetaxel-Teva liquid 20
mg/1 ml
48.37
69.00
10 %
Concentrate for infusion: Docetaxelum 20 mg/ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Docetaxel-Teva liquid 80
mg/4 ml
189.64
222.65
10 %
Concentrate for infusion: Docetaxelum 80mg / 4ml
Teva Pharma AG
● 
A / SL / SG
FB
G
IP
Docetaxel-Teva liquid 140
mg/7 ml
334.01
379.65
10 %
Concentrate for infusion: Docetaxelum 140mg / 7ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 40
mg/2 ml
37.83
57.55
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 40mg / 2ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 100
mg/5 ml
91.81
116.25
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 100mg / 5ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 300
mg/15 ml
245.64
283.55
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 300mg / 15ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
Irinotecan Fresenius 500
mg/25 ml
368.46
416.70
10 %
Concentrate for infusion: Irinotecani Hydrochloridum Trihydricum 500mg / 25ml
Fresenius Kabi
(Schweiz) AG
A / SL / SG
FB
G
IP
CI
Losartan Zentiva 50 mg
28
8.61
25.80
10 %
Coated tablets: Losartanum Kalicum 50 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Losartan Zentiva 50 mg
98
30.14
49.15
10 %
Coated tablets: Losartanum Kalicum 50 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Losartan Zentiva 100 mg
28
11.44
28.85
10 %
Coated tablets: Losartanum Kalicum 100 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Losartan Zentiva 100 mg
98
40.03
59.95
10 %
Coated tablets: Losartanum Kalicum 100 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Ozurdex
piece(s)
951.69
1051.45
10 %
: Dexamethasonum
AbbVie AG
A / SL
FB
G
IP
SmofKabiven,
Infusionsemulsion 493 ml
6 x 493 ml
PR
PR
k.A.
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven,
Infusionsemulsion 986 ml
4 x 986 ml
PR
PR
k.A.
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven,
Infusionsemulsion 1477 ml
4 x 1477 ml
PR
PR
k.A.
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven,
Infusionsemulsion 1970 ml
4 x 1970 ml
PR
PR
k.A.
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
CI
Sildenax 100 mg
4 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 100 mg
Drossapharm AG
B
FB
G
IP
CI
Sildenax 100 mg
12 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 100 mg
Drossapharm AG
B
FB
G
IP
CI
Dexeryl
500 g
PR
PR
k.A.
Cream: 3 Active Agents
Pierre Fabre Pharma SA
D
FB
G
IP
Gilenya 0.25 mg
7
PR
PR
k.A.
Capsules: Fingolimodum
Novartis Pharma
Schweiz AG
B
FB
G
IP
Gilenya 0.25 mg
28
PR
PR
k.A.
Capsules: Fingolimodum
Novartis Pharma
Schweiz AG
B
FB
G
IP
CM
Helveplatin 50 mg/10 ml
PR
PR
k.A.
Concentrate for infusion: Oxaliplatinum 50mg / 10ml
Helvepharm AG
A
FB
G
IP
CM
Helveplatin 100 mg/20 ml
PR
PR
k.A.
Concentrate for infusion: Oxaliplatinum 100mg / 20ml
Helvepharm AG
A
FB
G
IP
CM
Helveplatin 200 mg/40 ml
PR
PR
k.A.
Concentrate for infusion: Oxaliplatinum 200mg / 40ml
Helvepharm AG
A
FB
G
IP
CM
Helvetaxel 20 mg/1 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 20 mg/ml
Helvepharm AG
A
FB
G
IP
CM
Helvetaxel 80 mg/4 ml
PR
PR
k.A.
Concentrate for infusion: Docetaxelum 80mg / 4ml
Helvepharm AG
A
FB
G
IP
CI
Losartan Zentiva 12.5 mg
10
PR
PR
k.A.
Coated tablets: Losartanum Kalicum 12.5 mg
Helvepharm AG
B
FB
G
IP
CI
Sildenax 25 mg
4 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 25 mg
Drossapharm AG
B
FB
G
IP
CI
Sildenax 25 mg
12 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 25 mg
Drossapharm AG
B
FB
G
IP
CI
Sildenax 50 mg
4 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 50 mg
Drossapharm AG
B
FB
G
IP
CI
Sildenax 50 mg
12 Tablet(s)
PR
PR
k.A.
Coated tablets: Sildenafilum 50 mg
Drossapharm AG
B
FB
G
IP
Latanoprost Sandoz
2.5 ml
10.59
20.35
k.A.
Latanoprostum
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Latanoprost Sandoz
3 x 2.5 ml
31.66
52.75
k.A.
Latanoprostum
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Oxaliplatin Fresenius
82.01
110.55
k.A.
Oxaliplatinum 50 mg
Fresenius Kabi
(Schweiz) AG
A
FB
G
IP
Oxaliplatin Fresenius
163.39
203.95
k.A.
Oxaliplatinum 100 mg
Fresenius Kabi
(Schweiz) AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home